Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: Several studies suggest that severe asthmatic patients under oral steroids show higher risk of myopathy induced by steroids. Nevertheless, no conclusive data exist about the prolonged oral steroid therapy effects on the res- piratory muscles function. We didn't found correlation between the severity of obs- truction (evaluated by FEV1), hyperinflation (residual volu- me- RV) and the muscle pressures in both groups. Also, there were no significant correlation between the G1 PImax and oral steroid accumulated dose.
Conclusion: We found a significant compromise of the res- piratory muscle function in the both studied groups with severe asthma. The oral steroid therapy caused no additional adverse effect in muscle respiratory function even after a prolon- ged treatment. The compromise of the muscle respiratory function foun- ded can be justified by the prolonged exposition to inhaled steroids. Key-words: Asthma, respiratory muscles, oral steroids.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Risk Factors for Incidental Durotomy in Initial Posterior Decompression Surgery for Lumbar Central Canal Stenosis with Bilateral Neurogenic Claudication.
World Neurosurg
September 2025
Department of Orthopaedic Surgery, The University of Tokyo 7-3-1, Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan; University of Tokyo Spine Group (UTSG), 7-3-1, Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan. Electronic address:
Objective: To identify significant risk factors for incidental durotomy (ID) in initial posterior decompression surgery for lumbar central canal stenosis and to explore whether these risks vary by surgical approach through subgroup analyses.
Methods: This study included patients who underwent single-level posterior decompression surgery for lumbar central canal stenosis with bilateral neurogenic claudication at eight hospitals between April 2017 and May 2023. Patient demographics, comorbidities, and surgical details, including surgeon certification status, were collected.
Observational analysis of biological remission as a treatment target for severe asthma: UK severe asthma registry.
J Allergy Clin Immunol Pract
September 2025
Wellcome Wolfson Institute for Experimental Medicine, Queen's University Belfast, UK; Belfast Health and Social Care Trust, Belfast, UK.
Background: The aim of biologic therapies in severe asthma is inhibition of T2 inflammatory pathways.
Objective: We hypothesized that patients who achieve complete suppression of IL-5 & IL4/IL13 pathways with biologic therapy (FeNO <20ppb & blood eosinophil count (BEC) <0.15x10ˆ9, 'biological remission') would have better outcomes than patients with incomplete suppression of T2 biology.
Background: Central centrifugal cicatricial alopecia (CCCA) is a scarring alopecia primarily affecting Black women. To date, there are no standardized treatment regimens or approved medications for the treatment of CCCA. This single-center, open-label, clinical study investigated the efficacy of apremilast in the treatment of mild to moderate vertex-predominant CCCA.
View Article and Find Full Text PDF[Clinical efficacy analysis of Shibao Decoction in the treatment of late-onset hypogonadism with kidney essence deficiency].
Zhonghua Nan Ke Xue
July 2025
Department of Surgery, Yinchuan Hospital of Traditional Chinese Medicine, Ningxia Medical University, Yinchuan, Ningxia 750001, China.
Objective: To evaluate the clinical efficacy of "Shibao Decoction" in the management of late-onset hypogonadism (LOH) caused by deficiency of kidney essence.
Methods: Sixty male patients with late-onset hypogonadism of kidney essence deficiency type were randomly assigned to the treatment group and the control group, each with 30 cases. The patients in treatment group were treated with oral Shibao Decoction, while the control group was treated with oral Testosterone Undecanoate Capsules.
Premedication in the Outpatient Setting: IV Cetirizine or IV Diphenhydramine? A Literature Review.
J Infus Nurs
September 2025
Author Affiliation: BonSecours, Mercy Health, Hanover Outpatient Infusion Center, Mechanicsville, VA (Liverman); BonSecours, Mercy Health, Bremo Outpatient Infusion Center North Richmond, VA (Newman and Smith).
Background: Premedication regimens to prevent infusion-related reactions typically include steroids and first-generation antihistamines, primarily diphenhydramine. With the recent approval of intravenous cetirizine, a second-generation antihistamine, for acute urticaria and angioedema, reevaluating premedication standard regimens is warranted. This review explores whether cetirizine can improve efficiency and reduce side effects in outpatient infusion settings.
View Article and Find Full Text PDF